Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics

被引:28
作者
Cole, M
Price, L
Parry, A
Keir, MJ
Pearson, ADJ
Boddy, AV
Veal, GJ [1 ]
机构
[1] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Univ, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Newcastle Univ, Dept Med Phys, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[4] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
renal function; population pharmacokinetics; paediatric; cancer;
D O I
10.1038/sj.bjc.6601484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estimation of glomerular filtration rate (GFR) using the clearance of chromium 51 EDTA (Cr-51-EDTA) (or other radiolabelled isotopes) is reliable, but invasive and not always practicable. Mathematical models have been devised for estimating GFR using readily obtainable patient characteristics. Unfortunately, these models were developed using various patient populations and may not provide the optimal prediction of GFR in children with cancer. The current study uses population pharmacokinetics to determine the relationship between Cr-51-EDTA clearance, and patient covariates in 50 paediatric cancer patients. These models were validated using a separate group of 43 children and were compared with previously published models of renal function. Body size was the major determinant of Cr-51-EDTA clearance and inclusion of weight or surface area reduced the residual variability between individuals (coefficient of variation) from 61 to 32%. Serum creatinine was the only other parameter that significantly improved the model. Mean percentage error values of -5.0 and -1.1%were observed for models including weight alone or weight and creatinine, respectively, with precision estimates of 21.7 and 20.0%. These simple additive models provide a more rationale approach than the use of complex formulae, involving additional parameters, to predict renal function.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 25 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]  
BOECKMANN A, 1997, NONMEM USERS GUIDES
[3]  
Boyd E, 1935, SURFACE AREA HUMAN B
[4]   Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies [J].
Calvert, AH ;
Egorin, MJ .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) :11-16
[5]   CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].
CALVERT, AH ;
NEWELL, DR ;
GUMBRELL, LA ;
OREILLY, S ;
BURNELL, M ;
BOXALL, FE ;
SIDDIK, ZH ;
JUDSON, IR ;
GORE, ME ;
WILTSHAW, E .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756
[6]  
CHANTLER C, 1969, CLIN SCI, V37, P169
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis [J].
Dharnidharka, VR ;
Kwon, C ;
Stevens, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :221-226
[9]   CREATININE CLEARANCE - BEDSIDE ESTIMATE [J].
JELLIFFE, RW .
ANNALS OF INTERNAL MEDICINE, 1973, 79 (04) :604-605
[10]   The relationship between serum creatinine, serum cystatin C and glomerular filtration rate in pediatric renal transplant recipients: A pilot study [J].
Krieser, D ;
Rosenberg, AR ;
Kainer, G ;
Naidoo, D .
PEDIATRIC TRANSPLANTATION, 2002, 6 (05) :392-395